The new title is co-edited by Edward C.
Tidswell, Merck Exec. Dir. Of Sterile and Micro QA, and
Radhakrishna Tirumalai, Sr.
Principal Scientist at Merck Research Laboratories.
BETHESDA, Md., April 24,
2024 /PRNewswire-PRWeb/ -- Parenteral Drug
Association, Inc. (PDA) and UK-based Euromed Communications today
announced the publication of Industrial Pharmaceutical
Microbiology: Quality Control. This 500-page book includes 20
chapters from 19 industry leaders in pharmaceutical microbiology
quality control. Electronic copies are sold on both publishers'
bookstores for $299.00. Hardcopies
can be purchased for $340 at Euromed
Communication's website.
This book should become a staple reference
for the PDA membership, as pharmaceutical microbiology quality
control is a topic central to the challenges faced by many working
in our community.
Industrial Pharmaceutical Microbiology: Quality Control is an
in-depth, comprehensive survey of quality control methods in the
pharmaceutical microbiology laboratory to enable better
understanding and to ensure better developed, more compliant,
expedited procedures. The reference text brings together the
hitherto unavailable background, fundamental science, principles,
development, intended purpose, and specific answers to questions of
execution and qualification of compendial and related
microbiological test methods. Key topics include the types of
microbiological tests, reference strains and culture collections,
and equivalence of reference strain.
"This book should become a staple reference for the PDA
membership, as pharmaceutical microbiology quality control is a
topic central to the challenges faced by many working in our
community," said Walter Morris,
Senior Director of Publications and Press Relations, PDA. "Edward
and Radhakrishna have done an excellent job assembling well-known
authors who are frequent participants in other PDA activities."
For more information or to purchase the book, go to the PDA
Bookstore.
Parenteral Drug Association (PDA) is the leading global provider
of science, technology, and regulatory information. The PDA creates
awareness and understanding of important issues facing the
pharmaceutical and biopharmaceutical community and delivers
high-quality, relevant education to the industry. Since its
founding in 1946 as a nonprofit organization, PDA has been
committed to developing scientifically sound, practical technical
information and expertise to advance pharmaceutical /
biopharmaceutical manufacturing science and regulation, so members
can better serve patients. Go to https://www.pda.org/about-pda to
learn more.
Media Contact
Walter Morris, www.pda.org, 1
3016565900, morris@pda.org, www.pda.org
View original content to download
multimedia:https://www.prweb.com/releases/parenteral-drug-association-and-euromed-communications-release-second-co-published-book-industrial-pharmaceutical-microbiology-quality-control-302125814.html
SOURCE Parenteral Drug Association